ANXA2 and hepatocellular carcinoma: In a 2015 study aimed at assessing the diagnostic role of annexin A2 (ANXA2) as serum marker for 50 HCC patients, Annexin A2 levels were significantly higher in HCC patients’ sera compared with CLD patients’ sera (p < 0.001).